Found: 4
Select item for more details and to access through your institution.
Homologous Recombination Deficiency (HRD) as a Potential Pan-Cancer Biomarker for PARP Inhibition.
- Published in:
- Journal of Immunotherapy & Precision Oncology, 2024, v. 7, n. 3, p. 241, doi. 10.36401/JIPO-24-X2
- By:
- Publication type:
- Article
Ripretinib in gastrointestinal stromal tumor: the long-awaited step forward.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, v. 13, p. 1, doi. 10.1177/1758835920986498
- By:
- Publication type:
- Article
Ripretinib in gastrointestinal stromal tumor: the long-awaited step forward.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/1758835920986498
- By:
- Publication type:
- Article
Public and patient involvement: a survey on knowledge, experience and opinions among researchers within a precision oncology European project.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11262-x
- By:
- Publication type:
- Article